Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M167,762Revenue $M42,237Net Margin (%)27.0Altman Z-Score3.3
Enterprise Value $M182,547EPS $4.1Operating Margin %12.5Piotroski F-Score4
P/E(ttm)15.4Beneish M-Score-2.9Pre-tax Margin (%)40.0Higher ROA y-yY
Price/Book3.510-y EBITDA Growth Rate %5.4Quick Ratio1.3Cash flow > EarningsN
Price/Sales4.25-y EBITDA Growth Rate %4.0Current Ratio1.6Lower Leverage y-yN
Price/Free Cash Flow31.8y-y EBITDA Growth Rate %75.5ROA % (ttm)10.9Higher Current Ratio y-yN
Dividend Yield %3.0PEG3.9ROE % (ttm)23.3Less Shares Outstanding y-yY
Payout Ratio %46.0Shares Outstanding M2,825ROIC % (ttm)6.5Gross Margin Increase y-yN

Gurus Latest Trades with MRK

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
MRKVanguard Health Care Fund 2015-03-31 Add0.53%$56.06 - $63.03
($59.34)
$ 59.380%Add 12.04%40,096,948
MRKDodge & Cox 2015-03-31 Reduce-0.44%$56.06 - $63.03
($59.34)
$ 59.380%Reduce 24.30%25,448,977
MRKKahn Brothers 2015-03-31 Reduce-0.22%$56.06 - $63.03
($59.34)
$ 59.380%Reduce 2.18%1,029,815
MRKJoel Greenblatt 2015-03-31 Reduce-0.17%$56.06 - $63.03
($59.34)
$ 59.380%Reduce 35.28%676,758
MRKJames Barrow 2015-03-31 Add0.13%$56.06 - $63.03
($59.34)
$ 59.380%Add 7.03%24,464,116
MRKCharles Brandes 2015-03-31 Reduce-0.07%$56.06 - $63.03
($59.34)
$ 59.380%Reduce 3.69%2,221,791
MRKNWQ Managers 2015-03-31 Reduce-0.01%$56.06 - $63.03
($59.34)
$ 59.380%Reduce 9.00%76,286
MRKMario Gabelli 2015-03-31 Add0.01%$56.06 - $63.03
($59.34)
$ 59.380%Add 11.45%160,943
MRKKen Fisher 2015-03-31 Add$56.06 - $63.03
($59.34)
$ 59.380%Add 0.59%6,679,499
MRKKahn Brothers 2014-12-31 Reduce-0.54%$53.43 - $61.88
($58.42)
$ 59.382%Reduce 5.08%1,052,807
MRKVanguard Health Care Fund 2014-12-31 Add0.32%$53.43 - $61.88
($58.42)
$ 59.382%Add 7.08%35,788,048
MRKJoel Greenblatt 2014-12-31 Add0.23%$53.43 - $61.88
($58.42)
$ 59.382%Add 94.88%1,045,652
MRKFirst Eagle Investment 2014-12-31 Reduce-0.16%$53.43 - $61.88
($58.42)
$ 59.382%Reduce 99.16%9,050
MRKJoel Greenblatt 2014-09-30 Add0.24%$55.64 - $61.18
($58.89)
$ 59.381%Add 323.00%536,550
MRKFirst Eagle Investment 2014-09-30 Reduce-0.1%$55.64 - $61.18
($58.89)
$ 59.381%Reduce 38.25%1,083,826
MRKKahn Brothers 2014-09-30 Reduce-0.09%$55.64 - $61.18
($58.85)
$ 59.381%Reduce 0.97%1,109,189
MRKCharles Brandes 2014-09-30 Reduce-0.08%$55.64 - $61.18
($58.85)
$ 59.381%Reduce 4.69%2,320,288
MRKVanguard Health Care Fund 2014-09-30 Reduce-0.07%$55.64 - $61.18
($58.85)
$ 59.381%Reduce 1.38%33,420,748
MRKRobert Bruce 2014-09-30 Add0.06%$55.64 - $61.18
($58.85)
$ 59.381%Add 1.34%265,000
MRKDodge & Cox 2014-09-30 Reduce-0.05%$55.64 - $61.18
($58.85)
$ 59.381%Reduce 2.51%35,057,668
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

MRK is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


MRK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Schechter Adam HEVP & Pres-Global Human Health 2015-05-11Sell10,634$60.44-1.75view
Gerberding Julie L.EVP Strat Comm, Gl Pub Policy 2015-05-08Sell38,368$60.99-2.64view
Kuhlik Bruce NExe V-P & Gen Counsel 2015-05-04Sell56,064$60.2-1.36view
Holston Michael JEVP, Legal 2015-04-29Sell95,624$59.84-0.77view
Kuhlik Bruce NExe V-P & Gen Counsel 2015-04-29Sell156,902$59.82-0.74view
FRAZIER KENNETH CChairman, President & CEO 2015-02-18Sell5,164$58.671.21view
Deese Willie AExe V-P & Pres. MMD 2015-02-11Sell135,864$58.561.4view
WENDELL PETER CDirector 2015-02-09Sell5,000$58.761.06view
Schechter Adam HEVP & Pres-Global Human Health 2015-01-15Sell74,200$62.48-4.96view
FRAZIER KENNETH CChairman, President & CEO 2015-01-09Sell8,840$62.47-4.95view

Press Releases about MRK :

    Quarterly/Annual Reports about MRK:

      News about MRK:

      Articles On GuruFocus.com
      Endo International Acquires Par Pharmaceuticals For $8 Billion May 21 2015 
      Risk & Reward with Gilead Sciences Inc. (GILD) May 14 2015 
      Vanguard Adds to Four of Its Largest Stakes May 04 2015 
      Biogen Making A Breakthrough In Treating Alzheimer’s May 02 2015 
      Robert Bruce's Top Growth Stocks Apr 13 2015 
      Gilead Experiencing Bumpy Ride Despite Strong Fundamentals Apr 03 2015 
      Pfizer In The Process Of Making Path Breaking Vaccine Mar 18 2015 
      Johnson & Johnson Unfazed By $25 Million Fine Mar 13 2015 
      Bayer Goes Into Disinvestment Mode Due To Falling Profit Numbers Feb 27 2015 
      Abner Herrman's Top Three Holdings Feb 26 2015 

      More From Other Websites
      UPDATE 1-U.S. bird flu causes egg shortage, emergency measures May 23 2015
      Germany's Merck expects drug division to drive growth-Euro am Sonntag May 23 2015
      Germany's Merck expects drug division to drive growth-Euro am Sonntag May 23 2015
      U.S. bird flu causes egg shortage, emergency measures May 22 2015
      Expert Explains How To Play Merck In 2 Charts May 22 2015
      Merck KGaA Making Over Ambitious Growth Plans For Future? May 22 2015
      Merck Serono Announces CHMP Positive Opinion to Extend Kuvan Use to Children with PKU Below 4 Years... May 22 2015
      Merck follows Bristol with EU green light for immune cancer drug May 22 2015
      MSD Receives Positive CHMP Opinion for Pembrolizumab for the Treatment of Advanced Melanoma May 22 2015
      Merck Receives Positive CHMP Opinion for KEYTRUDA® (pembrolizumab) for the Treatment of Advanced... May 22 2015
      U.S. bird flu causing egg squeeze, emergency measures May 22 2015
      Merck Leads European Research Consortium on Printed Electronics May 22 2015
      Merck Millipore Introduces Single-Pass Tangential Flow Filtration with Pellicon® Cassettes for... May 21 2015
      Merck Millipore Enters Into Agreement to Acquire Exclusive Rights to Singulex’s Ultra-Sensitive... May 21 2015
      3 Big Pharmaceutical Stocks to Buy Right Now May 21 2015
      Merck Sharp & Dohme Federal Credit Union Significantly Expands Relationship with Fiserv May 20 2015
      For Displays and More: Merck Presents Expanded Portfolio and New Developments at SID Display Week... May 20 2015
      [$$] Merck Could Struggle to Hit Health Care Heights May 19 2015
      Merck KGaA profits decline on Sigma-Aldrich acquisition costs May 19 2015
      Merck KGaA Q1 Earnings Fall Y/Y, 2015 Sales View Retained - Analyst Blog May 19 2015

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      FEEDBACK